Switch to:
More From Other Websites
What Do Analysts Recommend for AbbVie? May 03 2016
How Does AbbVie’s Valuation Compare to Its Peers’? May 03 2016
ETF’s with exposure to AbbVie, Inc. : May 3, 2016 May 03 2016
AbbVie’s Viekira Pak Saw Weaker-than-Expected Performance May 03 2016
Gilead: What's Your Long Term Thesis? May 02 2016
Humira Continues to Be a Strong Growth Driver for AbbVie in 1Q16 May 02 2016
How Did AbbVie Perform in 1Q16? May 02 2016
AbbVie, Inc. :ABBV-US: Earnings Analysis: Q1, 2016 By the Numbers May 02 2016
ABBVIE INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of... Apr 29 2016
Worst may be over for embattled pharma Apr 29 2016
AbbVie (ABBV) Stock Price Target Hiked at Jefferies Apr 29 2016
Pharma stocks to bet on Apr 29 2016
AbbVie Gets European Medicines Agency's Positive Opinion For Its IMBRUVICA Apr 29 2016
AbbVie Doubles Down on M&A Apr 29 2016
AbbVie to Present at the Bank of America Merrill Lynch 2016 Global Health Care Conference Apr 29 2016
European Medicines Agency Issues Positive Opinion for the Use of IMBRUVICA® (ibrutinib) as a... Apr 29 2016
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment... Apr 29 2016
AbbVie to Present at the Bank of America Merrill Lynch 2016 Global Health Care Conference Apr 29 2016
Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment... Apr 29 2016
Biogen, AbbVie multiple sclerosis drug wins EU green light Apr 29 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK